RxNorm Semantic Concepts Index - 401
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "401".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 40111 | GP120 V-FMS protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40111 | GP120 V-FMS protein | Designated preferred name (PT) | NO | |
RxCUI: 40111 | GP120 V-FMS protein | Full form of descriptor (FN) | NO | |
RxCUI: 40112 | Granulocyte colony stimulating factor | Designated preferred name (PT) | NO | |
RxCUI: 40112 | Granulocyte colony stimulating factor | Full form of descriptor (FN) | NO | |
RxCUI: 40112 | Granulocyte colony stimulating factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40112 | Granulocyte colony stimulating factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40112 | Granulocyte colony stimulating factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40113 | Granulocyte macrophage colony stimulating factor | Designated preferred name (PT) | NO | |
RxCUI: 40113 | Granulocyte macrophage colony stimulating factor | Full form of descriptor (FN) | NO | |
RxCUI: 40113 | Granulocyte macrophage colony stimulating factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40113 | Granulocyte macrophage colony stimulating factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40113 | Granulocyte macrophage colony stimulating factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40114 | Guanfacine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 40114 | Guanfacine | Designated preferred name (PT) | YES | |
RxCUI: 40114 | Guanfacine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 40114 | Guanfacine | Full form of descriptor (FN) | YES | |
RxCUI: 40114 | Guanfacine | Designated preferred name (PT) | YES | |
RxCUI: 40114 | Guanfacine | Full form of descriptor (FN) | YES | |
RxCUI: 40137 | Tamoxifen citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 40137 | Tamoxifen citrate | Designated preferred name (PT) | YES | |
RxCUI: 40137 | Tamoxifen citrate | Full form of descriptor (FN) | YES | |
RxCUI: 40138 | Iloprost | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 40138 | Iloprost | Designated preferred name (PT) | YES | |
RxCUI: 40138 | Iloprost | Full form of descriptor (FN) | YES | |
RxCUI: 40138 | Iloprost | Designated preferred name (PT) | YES | |
RxCUI: 40138 | Iloprost | Full form of descriptor (FN) | YES | |
RxCUI: 40144 | Levothyroxine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 40144 | Levothyroxine sodium | Designated preferred name (PT) | YES | |
RxCUI: 40144 | Levothyroxine sodium | Full form of descriptor (FN) | YES | |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | Full form of descriptor (FN) | NO | |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | British preferred term (PTGB) | NO | |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | Designated preferred name (PT) | NO | |
RxCUI: 40147 | LFA-1 - lymphocyte function-associated antigen-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401472 | Escherichia coli O157:H7 Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401472 | Escherichia coli O157:H7 Ag | Full form of descriptor (FN) | NO | |
RxCUI: 401472 | Escherichia coli O157:H7 Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401472 | Escherichia coli O157:H7 Ag | Designated preferred name (PT) | NO | |
RxCUI: 401495 | Immunoglobulin, L chain, lambda amyloid antigen | Designated preferred name (PT) | NO | |
RxCUI: 401495 | Immunoglobulin, L chain, lambda amyloid antigen | Full form of descriptor (FN) | NO | |
RxCUI: 401502 | Leishmania braziliensis antibody | Designated preferred name (PT) | NO | |
RxCUI: 401502 | Leishmania braziliensis antibody | Full form of descriptor (FN) | NO | |
RxCUI: 40158 | Colony-stimulating factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40158 | Colony-stimulating factor 1 | Designated preferred name (PT) | NO | |
RxCUI: 40158 | Colony-stimulating factor 1 | Full form of descriptor (FN) | NO | |
RxCUI: 40158 | Colony-stimulating factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40158 | Colony-stimulating factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40159 | CD11b/CD18 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401594 | Cethromycin | Designated preferred name (PT) | NO | |
RxCUI: 401594 | Cethromycin | Full form of descriptor (FN) | NO | |
RxCUI: 401594 | Cethromycin | Designated preferred name (PT) | NO | |
RxCUI: 401594 | Cethromycin | Full form of descriptor (FN) | NO | |
RxCUI: 401599 | nitrous oxide 85 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 40160 | MAF | Designated preferred name (PT) | NO | |
RxCUI: 40160 | MAF | Full form of descriptor (FN) | NO | |
RxCUI: 40160 | MAF | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401600 | carbon dioxide / nitrous oxide Gas for Inhalation | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 401608 | carbon dioxide 99.2 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 401609 | carbon dioxide 99.5 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 401610 | carbon dioxide 99.6 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 401611 | carbon dioxide 99.8 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 401612 | carbon dioxide 99.9 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 401615 | dichlorodifluoromethane 100 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 401616 | dichlorodifluoromethane Gas for Inhalation | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 401617 | nitrous oxide 99.2 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 401618 | nitrous oxide 99.5 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 401619 | nitrous oxide 99.8 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 401626 | Lymphocyte antigen CD102 | Designated preferred name (PT) | NO | |
RxCUI: 401626 | Lymphocyte antigen CD102 | Full form of descriptor (FN) | NO | |
RxCUI: 401636 | mineral oil, light 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 401637 | mineral oil, light Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 401638 | heavy mineral oil 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 401639 | heavy mineral oil Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 401640 | mineral oil, light Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 401646 | citric acid 66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 401649 | gluconolactone 1.98 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 40165 | Methacholine chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 40165 | Methacholine chloride | Designated preferred name (PT) | NO | |
RxCUI: 40165 | Methacholine chloride | Full form of descriptor (FN) | NO | |
RxCUI: 401650 | magnesium carbonate 31.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 401651 | citric acid / gluconolactone / magnesium carbonate Irrigation Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 40169 | Moracizine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40169 | Moracizine | Full form of descriptor (FN) | NO | |
RxCUI: 40169 | Moracizine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40169 | Moracizine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 40169 | Moracizine | Designated preferred name (PT) | NO | |
RxCUI: 40169 | Moracizine | Designated preferred name (PT) | NO | |
RxCUI: 40169 | Moracizine | Full form of descriptor (FN) | NO | |
RxCUI: 401690 | Blood group antibody Warrior | Designated preferred name (PT) | NO | |
RxCUI: 401690 | Blood group antibody Warrior | Full form of descriptor (FN) | NO | |
RxCUI: 401690 | Blood group antibody Warrior | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401713 | Carglutamic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 401713 | Carglutamic acid | Designated preferred name (PT) | YES | |
RxCUI: 401713 | Carglutamic acid | Full form of descriptor (FN) | YES | |
RxCUI: 401713 | Carglutamic acid | Designated preferred name (PT) | YES | |
RxCUI: 401713 | Carglutamic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 401713 | Carglutamic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 401713 | Carglutamic acid | Full form of descriptor (FN) | YES | |
RxCUI: 401714 | dolasetron mesylate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401714 | dolasetron mesylate 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401714 | dolasetron mesylate 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401714 | dolasetron mesylate 200 MG Oral Tablet | Designated preferred name (PT) | NO | |
RxCUI: 401714 | dolasetron mesylate 200 MG Oral Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 401742 | Substance with phosphodiesterase 5 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
RxCUI: 401742 | Substance with phosphodiesterase 5 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
RxCUI: 401742 | Substance with phosphodiesterase 5 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
RxCUI: 401742 | Substance with phosphodiesterase 5 inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401742 | Substance with phosphodiesterase 5 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
RxCUI: 401744 | Peroxidase stain | Designated preferred name (PT) | NO | |
RxCUI: 401744 | Peroxidase stain | Full form of descriptor (FN) | NO | |
RxCUI: 401746 | Antibody to gangliosides | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401746 | Antibody to gangliosides | Designated preferred name (PT) | NO | |
RxCUI: 401746 | Antibody to gangliosides | Full form of descriptor (FN) | NO | |
RxCUI: 401747 | IgG antibody to ganglioside | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401747 | IgG antibody to ganglioside | Designated preferred name (PT) | NO | |
RxCUI: 401747 | IgG antibody to ganglioside | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401747 | IgG antibody to ganglioside | Full form of descriptor (FN) | NO | |
RxCUI: 401748 | IgM antibody to ganglioside | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401748 | IgM antibody to ganglioside | Designated preferred name (PT) | NO | |
RxCUI: 401748 | IgM antibody to ganglioside | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401748 | IgM antibody to ganglioside | Full form of descriptor (FN) | NO | |
RxCUI: 401749 | CM1 - centrocyte marker 1 IgG antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401749 | CM1 - centrocyte marker 1 IgG antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401749 | CM1 - centrocyte marker 1 IgG antibody | Full form of descriptor (FN) | NO | |
RxCUI: 401749 | CM1 - centrocyte marker 1 IgG antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401749 | CM1 - centrocyte marker 1 IgG antibody | Designated preferred name (PT) | NO | |
RxCUI: 401752 | Wood dust specific IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401752 | Wood dust specific IgE | Designated preferred name (PT) | NO | |
RxCUI: 401752 | Wood dust specific IgE | Full form of descriptor (FN) | NO | |
RxCUI: 401753 | Haddock specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401753 | Haddock specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401753 | Haddock specific immunoglobulin E | Designated preferred name (PT) | NO | |
RxCUI: 401753 | Haddock specific immunoglobulin E | Full form of descriptor (FN) | NO | |
RxCUI: 401754 | Salicylate specific IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401754 | Salicylate specific IgE | Designated preferred name (PT) | NO | |
RxCUI: 401754 | Salicylate specific IgE | Full form of descriptor (FN) | NO | |
RxCUI: 401755 | Acetyl salicylic acid specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401755 | Acetyl salicylic acid specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401755 | Acetyl salicylic acid specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401755 | Acetyl salicylic acid specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401755 | Acetyl salicylic acid specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401755 | Acetyl salicylic acid specific immunoglobulin E | Designated preferred name (PT) | NO | |
RxCUI: 401755 | Acetyl salicylic acid specific immunoglobulin E | Full form of descriptor (FN) | NO | |
RxCUI: 401756 | Poultry feathers specific IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401756 | Poultry feathers specific IgE | Designated preferred name (PT) | NO | |
RxCUI: 401756 | Poultry feathers specific IgE | Full form of descriptor (FN) | NO | |
RxCUI: 401757 | Caged bird feathers specific IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401757 | Caged bird feathers specific IgE | Designated preferred name (PT) | NO | |
RxCUI: 401757 | Caged bird feathers specific IgE | Full form of descriptor (FN) | NO | |
RxCUI: 401758 | Resin isocyanate specific IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401758 | Resin isocyanate specific IgE | Designated preferred name (PT) | NO | |
RxCUI: 401758 | Resin isocyanate specific IgE | Full form of descriptor (FN) | NO | |
RxCUI: 401759 | Diphenylmethane diisocyanate specific IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401759 | Diphenylmethane diisocyanate specific IgE | Designated preferred name (PT) | NO | |
RxCUI: 401759 | Diphenylmethane diisocyanate specific IgE | Full form of descriptor (FN) | NO | |
RxCUI: 40176 | Antisense oligonucleotide | Designated preferred name (PT) | NO | |
RxCUI: 40176 | Antisense oligonucleotide | Full form of descriptor (FN) | NO | |
RxCUI: 40177 | V-FMS protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40177 | V-FMS protein | Designated preferred name (PT) | NO | |
RxCUI: 40177 | V-FMS protein | Full form of descriptor (FN) | NO | |
RxCUI: 40177 | V-FMS protein | Designated preferred name (PT) | NO | |
RxCUI: 40177 | V-FMS protein | Full form of descriptor (FN) | NO | |
RxCUI: 40177 | V-FMS protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 40178 | V-MYC protein P55 | Designated preferred name (PT) | NO | |
RxCUI: 40178 | V-MYC protein P55 | Full form of descriptor (FN) | NO | |
RxCUI: 40178 | V-MYC protein P55 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 4018 | Calciferol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 4018 | Calciferol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 4018 | Calciferol | Designated preferred name (PT) | YES | |
RxCUI: 4018 | Calciferol | Full form of descriptor (FN) | YES | |
RxCUI: 4018 | Calciferol | Designated preferred name (PT) | YES | |
RxCUI: 4018 | Calciferol | Full form of descriptor (FN) | YES | |
RxCUI: 4018 | Calciferol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 401817 | Plant N-3 fatty acid | Designated preferred name (PT) | NO | |
RxCUI: 401817 | Plant N-3 fatty acid | Full form of descriptor (FN) | NO | |
RxCUI: 401817 | Plant N-3 fatty acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401853 | U snRNP | Designated preferred name (PT) | NO | |
RxCUI: 401853 | U snRNP | Full form of descriptor (FN) | NO | |
RxCUI: 401853 | U snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401854 | U8 snRNP | Designated preferred name (PT) | NO | |
RxCUI: 401854 | U8 snRNP | Full form of descriptor (FN) | NO | |
RxCUI: 401854 | U8 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401855 | U9 snRNP | Designated preferred name (PT) | NO | |
RxCUI: 401855 | U9 snRNP | Full form of descriptor (FN) | NO | |
RxCUI: 401855 | U9 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401856 | U10 snRNP | Designated preferred name (PT) | NO | |
RxCUI: 401856 | U10 snRNP | Full form of descriptor (FN) | NO | |
RxCUI: 401856 | U10 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401857 | Heterogeneous snRNP | Designated preferred name (PT) | NO | |
RxCUI: 401857 | Heterogeneous snRNP | Full form of descriptor (FN) | NO | |
RxCUI: 401857 | Heterogeneous snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401872 | Platelet associated IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401872 | Platelet associated IgG | Designated preferred name (PT) | NO | |
RxCUI: 401872 | Platelet associated IgG | Full form of descriptor (FN) | NO | |
RxCUI: 401873 | Allergen specific IgM | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401873 | Allergen specific IgM | Designated preferred name (PT) | NO | |
RxCUI: 401873 | Allergen specific IgM | Full form of descriptor (FN) | NO | |
RxCUI: 401883 | lutropin alfa 75 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401885 | VHL disease tumor suppressor protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401885 | VHL disease tumor suppressor protein | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 401885 | VHL disease tumor suppressor protein | Designated preferred name (PT) | NO | |
RxCUI: 401885 | VHL disease tumor suppressor protein | Full form of descriptor (FN) | NO | |
RxCUI: 401885 | VHL disease tumor suppressor protein | British preferred term (PTGB) | NO | |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | Designated preferred name (PT) | NO | |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | Designated preferred name (PT) | NO | |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | British preferred term (PTGB) | NO | |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401886 | Guanine nucleoside analogue-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Designated preferred name (PT) | NO | |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Designated preferred name (PT) | NO | |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Full form of descriptor (FN) | NO | |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401891 | Noradrenaline reuptake inhibitor | Full form of descriptor (FN) | NO | |
RxCUI: 401900 | Antibody to avian serum protein | Designated preferred name (PT) | NO | |
RxCUI: 401900 | Antibody to avian serum protein | Full form of descriptor (FN) | NO | |
RxCUI: 401901 | Antibody to fowl serum protein | Designated preferred name (PT) | NO | |
RxCUI: 401901 | Antibody to fowl serum protein | Full form of descriptor (FN) | NO | |
RxCUI: 401902 | Blood group antibody KREP | Designated preferred name (PT) | NO | |
RxCUI: 401902 | Blood group antibody KREP | Full form of descriptor (FN) | NO | |
RxCUI: 401903 | Blood group antibody BOW | Designated preferred name (PT) | NO | |
RxCUI: 401903 | Blood group antibody BOW | Full form of descriptor (FN) | NO | |
RxCUI: 401904 | Blood group antibody NFLD | Designated preferred name (PT) | NO | |
RxCUI: 401904 | Blood group antibody NFLD | Full form of descriptor (FN) | NO | |
RxCUI: 401905 | Blood group antibody SW1 | Designated preferred name (PT) | NO | |
RxCUI: 401905 | Blood group antibody SW1 | Full form of descriptor (FN) | NO | |
RxCUI: 401932 | evening primrose oil 20 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401932 | evening primrose oil 20 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401932 | evening primrose oil 20 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401933 | valdecoxib 40 MG Oral Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 401933 | valdecoxib 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401933 | valdecoxib 40 MG Oral Tablet | Designated preferred name (PT) | NO | |
RxCUI: 401933 | valdecoxib 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401938 | migLUstat 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 401938 | migLUstat 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 401938 | migLUstat 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 401938 | migLUstat 100 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 401938 | migLUstat 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 401941 | methyl 5-aminolevulinate 16 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401941 | methyl 5-aminolevulinate 16 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401941 | methyl 5-aminolevulinate 16 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401941 | methyl 5-aminolevulinate 16 % Topical Cream | Designated preferred name (PT) | NO | |
RxCUI: 401941 | methyl 5-aminolevulinate 16 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 401941 | methyl 5-aminolevulinate 16 % Topical Cream | Full form of descriptor (FN) | NO | |
RxCUI: 401953 | risperiDONE 1 MG Disintegrating Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 401953 | risperiDONE 1 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 401953 | risperiDONE 1 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 401953 | risperiDONE 1 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 401953 | risperiDONE 1 MG Disintegrating Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 401954 | risperiDONE 2 MG Disintegrating Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 401954 | risperiDONE 2 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 401954 | risperiDONE 2 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 401954 | risperiDONE 2 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 401954 | risperiDONE 2 MG Disintegrating Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 401965 | ramipril 1.25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 401965 | ramipril 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 401965 | ramipril 1.25 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 401965 | ramipril 1.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 401967 | Drugs used in neuropathic pain | Designated preferred name (PT) | NO | |
RxCUI: 401967 | Drugs used in neuropathic pain | Full form of descriptor (FN) | NO | |
RxCUI: 401968 | ramipril 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 401968 | ramipril 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 401968 | ramipril 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 401968 | ramipril 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 401969 | Carbon (13-C) urea 50 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 401969 | Carbon (13-C) urea 50 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 401971 | olmesartan medoxomil 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401971 | olmesartan medoxomil 10 MG Oral Tablet | Designated preferred name (PT) | NO | |
RxCUI: 401971 | olmesartan medoxomil 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401971 | olmesartan medoxomil 10 MG Oral Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 401973 | nabilone 2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401973 | nabilone 2 MG Oral Capsule | Designated preferred name (PT) | NO | |
RxCUI: 401973 | nabilone 2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401973 | nabilone 2 MG Oral Capsule | Full form of descriptor (FN) | NO | |
RxCUI: 401974 | nabilone 500 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401974 | nabilone 500 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401974 | nabilone 500 MCG Oral Capsule | Designated preferred name (PT) | NO | |
RxCUI: 401974 | nabilone 500 MCG Oral Capsule | Full form of descriptor (FN) | NO | |
RxCUI: 401975 | nabilone 250 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401975 | nabilone 250 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401975 | nabilone 250 MCG Oral Capsule | Designated preferred name (PT) | NO | |
RxCUI: 401975 | nabilone 250 MCG Oral Capsule | Full form of descriptor (FN) | NO | |
RxCUI: 401976 | ibuprofen 300 MG / pseudoephedrine HCl 45 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401976 | ibuprofen 300 MG / pseudoephedrine HCl 45 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 401976 | ibuprofen 300 MG / pseudoephedrine HCl 45 MG Oral Capsule | Designated preferred name (PT) | NO | |
RxCUI: 401976 | ibuprofen 300 MG / pseudoephedrine HCl 45 MG Oral Capsule | Full form of descriptor (FN) | NO | |
RxCUI: 401978 | SUMAtriptan 10 MG/ACTUAT Nasal Spray | Full form of descriptor (FN) | YES | |
RxCUI: 401978 | SUMAtriptan 10 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 401978 | SUMAtriptan 10 MG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 401978 | SUMAtriptan 10 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 401978 | SUMAtriptan 10 MG/ACTUAT Nasal Spray | Designated preferred name (PT) | YES | |
RxCUI: 401978 | SUMAtriptan 10 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 401978 | SUMAtriptan 10 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 401981 | enfuvirtide 90 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 401981 | enfuvirtide 90 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 401981 | enfuvirtide 90 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 401981 | enfuvirtide 90 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 401989 | temoporfin 4 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
RxCUI: 401989 | temoporfin 4 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 401989 | temoporfin 4 MG/ML Injectable Solution | Designated preferred name (PT) | NO |